BioXcel Therapeutics, Inc. (BTAIQ)
0.052
+0.01
(+15.56%)
USD |
OTCM |
Oct 02, 16:00
BioXcel Therapeutics Market Cap : 1.628M for Oct. 2, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 02, 2026 | 1.628M |
| October 01, 2026 | 1.409M |
| September 30, 2026 | 1.549M |
| September 29, 2026 | 1.534M |
| September 28, 2026 | 1.286M |
| September 25, 2026 | 1.202M |
| September 24, 2026 | 1.105M |
| September 23, 2026 | 1.409M |
| September 22, 2026 | 1.395M |
| September 21, 2026 | 1.925M |
| September 18, 2026 | 1.816M |
| September 17, 2026 | 2.351M |
| September 16, 2026 | 2.094M |
| September 15, 2026 | 1.399M |
| September 14, 2026 | 1.412M |
| September 11, 2026 | 1.597M |
| September 10, 2026 | 1.565M |
| September 09, 2026 | 1.471M |
| September 08, 2026 | 1.344M |
| September 04, 2026 | 2.313M |
| September 03, 2026 | 3.678M |
| September 02, 2026 | 3.350M |
| September 01, 2026 | 4.289M |
| August 31, 2026 | 5.096M |
| August 28, 2026 | 5.679M |
| Date | Value |
|---|---|
| August 27, 2026 | 22.50M |
| August 26, 2026 | 24.42M |
| August 25, 2026 | 23.23M |
| August 24, 2026 | 23.81M |
| August 21, 2026 | 25.16M |
| August 20, 2026 | 25.00M |
| August 19, 2026 | 25.90M |
| August 18, 2026 | 24.80M |
| August 17, 2026 | 27.86M |
| August 14, 2026 | 37.25M |
| August 13, 2026 | 35.37M |
| August 12, 2026 | 33.18M |
| August 11, 2026 | 29.17M |
| August 10, 2026 | 25.12M |
| August 07, 2026 | 24.41M |
| August 06, 2026 | 22.48M |
| August 05, 2026 | 22.76M |
| August 04, 2026 | 23.30M |
| August 03, 2026 | 22.95M |
| July 31, 2026 | 21.88M |
| July 30, 2026 | 21.47M |
| July 29, 2026 | 21.72M |
| July 28, 2026 | 22.88M |
| July 27, 2026 | 23.47M |
| July 24, 2026 | 22.95M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Agenus, Inc. | 356.27M |
| Amgen, Inc. | 217.88B |
| BioCryst Pharmaceuticals, Inc. | 2.086B |
| Imunon, Inc. | 5.972M |
| Curis, Inc. | 1.566M |
Market Cap Related Metrics
| PS Ratio | 1.406 |
| Price | 0.052 |
| Earnings Yield | -8.13K% |